Locus heterogeneity is one of those genetics buzzphrases that feels abstract… until you realize it’s exactly why two patients can look clinically identical yet have completely different genes at fault. For Step 1, it’s a high-yield concept that ties together inheritance patterns, genotype–phenotype relationships, diagnostic testing strategy, and classic diseases you already know from First Aid.
What “locus heterogeneity” actually means
Definition: Locus heterogeneity occurs when mutations in different genes (different loci) cause the same or very similar clinical phenotype.
- Same disease/phenotype
- Different genes
- Often converges on the same pathway or same physiologic function
Quick contrast table (know these cold)
| Concept | What varies? | What stays the same? | Classic example |
|---|---|---|---|
| Locus heterogeneity | Gene/locus | Phenotype | Osteogenesis imperfecta (COL1A1 vs COL1A2), albinism (multiple genes) |
| Allelic heterogeneity | Mutation within same gene | Disease entity | Cystic fibrosis (many CFTR variants) |
| Variable expressivity | Severity/features | Genotype | NF1 severity differs across patients |
| Incomplete penetrance | Whether phenotype appears | Genotype | BRCA mutation carriers not all get cancer |
| Pleiotropy | Phenotypes (multiple systems) | Gene | FBN1 → Marfan syndrome |
| Genetic heterogeneity (umbrella) | Could be locus + allelic | Phenotype category | Retinitis pigmentosa (many genes, many variants) |
Why it happens (pathophysiology you can reason through)
Locus heterogeneity is basically systems biology in disguise: multiple genes can “feed into” the same phenotype because they participate in:
1) The same molecular complex
If a structure needs multiple subunits, breaking any key subunit can yield a similar phenotype.
- Example pattern: ciliary proteins → ciliopathies; sarcomere proteins → cardiomyopathies
2) The same pathway
Different steps in a pathway can converge on one final functional bottleneck.
- Example pattern: DNA repair genes → cancer predisposition syndromes with overlapping phenotypes
3) The same organ-level physiologic function
Different proteins can be required for one physiologic output (eg, vision, pigmentation, hearing).
Step 1 takeaway: When you see a “single phenotype,” don’t assume “single gene.”
Clinical presentation: how it shows up on exams
You’ll most often see locus heterogeneity tested in these ways:
Pattern A: “Same disease label, multiple genes”
The stem tells you a classic phenotype; the question asks why different families have different mutations.
- “Two unrelated patients have classic findings of osteogenesis imperfecta; genetic testing shows different genes mutated.”
Pattern B: “Negative test doesn’t rule it out”
A patient has a classic phenotype, but a single-gene test is negative. What’s next?
- Think: broader panel, exome, or copy-number analysis, depending on context.
Pattern C: “Genotype doesn’t perfectly predict phenotype across families”
Different genes causing the “same” disease can still lead to:
- slightly different severity
- different extra findings
- different prognosis and treatment response
That’s not a contradiction—it's common in locus heterogeneity.
Diagnosis: the high-yield testing strategy
Stepwise approach (USMLE-style logic)
- Recognize the phenotype (clinical + family history)
- Ask: is this classically genetically heterogeneous?
- Choose the right test type.
Testing options (and when they shine)
| Test | Best for | Key limitation |
|---|---|---|
| Single-gene sequencing | One classic gene explains most cases | Misses locus heterogeneity; can miss CNVs |
| Targeted multigene panel | Phenotype with known locus heterogeneity | Limited to included genes |
| Chromosomal microarray (CMA) | CNVs, developmental delay/autism | Doesn’t detect balanced translocations; limited for single-nucleotide variants |
| Whole exome sequencing (WES) | Broad differential; many possible genes | May miss deep intronic variants; incidental findings |
| Whole genome sequencing (WGS) | Most comprehensive | Cost/interpretation burden |
High-yield point: In locus heterogeneity, panels are often first-line because they cover the most common genes for that phenotype efficiently.
Classic vignette clue
“Genetic testing for gene X is negative, but suspicion remains high.”
That’s your cue to think:
- locus heterogeneity (different gene), or
- allelic heterogeneity (variant type missed), or
- wrong test modality (e.g., sequencing vs deletion/duplication)
Treatment: why locus heterogeneity matters clinically
Even when two genes produce similar clinical pictures, treatment may differ because the genes map to different mechanisms.
Practical consequences
- Prognosis differs by gene (severity, organ involvement, age of onset)
- Targeted therapies may apply only to certain genotypes
- Family counseling and recurrence risk interpretation can be more nuanced
- Trial eligibility can be gene-specific
Step 1 angle: Locus heterogeneity explains why “one-size-fits-all genetic counseling” can fail unless the causative locus is known.
High-yield diseases and associations (know at least a few)
Below are classic First Aid–friendly examples where different genes can cause similar phenotypes.
Osteogenesis imperfecta (OI)
- Classic phenotype: fractures with minimal trauma, blue sclerae, hearing loss, dental imperfections
- Locus heterogeneity example:
- COL1A1 or COL1A2 mutations → abnormal type I collagen
First Aid cross-reference: Biochemistry/Genetics sections on collagen synthesis disorders (OI contrasted with Ehlers-Danlos, Alport).
Albinism
- Classic phenotype: reduced melanin, vision problems (photophobia, nystagmus), light skin/hair/eyes depending on type
- Locus heterogeneity: multiple genes in melanin synthesis/trafficking can cause albinism (e.g., TYR and others)
First Aid cross-reference: Genetics—autosomal recessive disorders; dermatology/ophthalmology associations (hypopigmentation, vision findings).
Retinitis pigmentosa (RP) (classic “genetically heterogeneous” board favorite)
- Progressive night blindness, peripheral vision loss (tunnel vision)
- Locus heterogeneity: many different genes can cause similar retinal degeneration
Testable twist: Same phenotype can show AD, AR, or X-linked inheritance depending on the gene—this is an easy way for NBME to test heterogeneity without naming it.
First Aid cross-reference: Neuro/ophtho—retinal degeneration patterns; genetics principles.
Hypertrophic cardiomyopathy (HCM) (more Step 2–leaning but still fair game)
- Exertional syncope, systolic murmur (increased with Valsalva), sudden cardiac death in athletes
- Locus heterogeneity: multiple sarcomere genes can cause HCM
First Aid cross-reference: Cardiovascular—HCM physiology and murmur maneuvers; genetics principles.
How locus heterogeneity gets tested (question templates)
Template 1: Define the concept
“Mutations in different genes cause the same clinical disorder.”
Answer: Locus heterogeneity
Template 2: Interpretation of genetic testing
“Patient has classic phenotype; sequencing of the ‘most common’ gene is negative.”
Best next step often:
- Multigene panel for that phenotype
- or WES if broad differential / panel unrevealing
Template 3: Inheritance pattern confusion across families
“Same clinical diagnosis appears autosomal dominant in one pedigree and autosomal recessive in another.”
Think: genetic heterogeneity, often locus heterogeneity (different genes with different inheritance patterns can yield similar clinical endpoints).
Memory hooks (quick, sticky, exam-safe)
- “Locus” = location → different “addresses” (genes) causing same picture
- If a disease involves a pathway, expect multiple genes can break it
- Negative single-gene test ≠ ruled out when locus heterogeneity is common
Rapid review (what you should be able to say in 15 seconds)
- Locus heterogeneity: same phenotype, different genes.
- Common in disorders involving multi-protein complexes or shared pathways.
- Impacts testing strategy: go from single-gene → panel/exome when suspicion remains high.
- Know classic examples like OI (COL1A1/COL1A2) and retinitis pigmentosa (many genes).